These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 21334386)

  • 1. Gene-specific contributions to mumps virus neurovirulence and neuroattenuation.
    Sauder CJ; Zhang CX; Ngo L; Werner K; Lemon K; Duprex WP; Malik T; Carbone K; Rubin SA
    J Virol; 2011 Jul; 85(14):7059-69. PubMed ID: 21543475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology, pathogenesis and pathology of mumps virus.
    Rubin S; Eckhaus M; Rennick LJ; Bamford CG; Duprex WP
    J Pathol; 2015 Jan; 235(2):242-52. PubMed ID: 25229387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Biology and Epidemiology of Neurotropic Viruses.
    Abdullahi AM; Sarmast ST; Singh R
    Cureus; 2020 Aug; 12(8):e9674. PubMed ID: 32923269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
    Xu J; Zhang Y; Qu P; Shamseldin MM; Yoo SJ; Misny J; Thongpan I; Kc M; Hall JM; Evans JP; Eltobgy M; Lu M; Ye C; Chamblee M; Liang X; Martinez-Sobrido L; Amer AO; Yount JS; Boyaka PN; Peeples ME; Liu SL; Dubey P; Li J
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2220403120. PubMed ID: 37796985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Study on MNVT of OPV Type I and III Reference Products in Different Periods.
    Wang X; Ren R; Ma B; Xie J; Ma Y; Luo H; Guo Y; Ding L; Zhang L; Zhang M; Wang T; Shuang Z; Zhu X
    Diseases; 2023 Feb; 11(1):. PubMed ID: 36810542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
    Zhang Y; Lu M; Mahesh KC; Kim E; Shamseldin MM; Ye C; Dravid P; Chamblee M; Park JG; Hall JM; Trivedi S; Chaiwatpongsakorn S; Kenny AD; Murthy SS; Sharma H; Liang X; Yount JS; Kapoor A; Martinez-Sobrido L; Dubey P; Boyaka PN; Peeples ME; Li J
    Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2201616119. PubMed ID: 35895717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Highly Attenuated Mumps Virus Strain of Genotype F Generated by Passaging in Vero Cells.
    Zhang Y; Xie L; Chai B; Ruan J; Gu Y; Niu B; Zhang Y; Fu Z; An Q; Tian D
    Virol Sin; 2021 Apr; 36(2):337-340. PubMed ID: 32990936
    [No Abstract]   [Full Text] [Related]  

  • 8. The potential dysfunction of otolith organs in patients after mumps infection.
    Zhou YJ; Yu J; Wu YZ; Tian L; Han Z; Wang J; Chi FL
    PLoS One; 2017; 12(7):e0181907. PubMed ID: 28746415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity.
    Halassy B; Kurtović T; Brgles M; Lang Balija M; Forčić D
    Hum Vaccin Immunother; 2015; 11(10):2446-54. PubMed ID: 26376015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mumps virus inhibits migration of primary human macrophages toward a chemokine gradient through a TNF-alpha dependent mechanism.
    Briggs CM; Mayer AE; Parks GD
    Virology; 2012 Nov; 433(1):245-52. PubMed ID: 22935226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
    Mire CE; Miller AD; Carville A; Westmoreland SV; Geisbert JB; Mansfield KG; Feldmann H; Hensley LE; Geisbert TW
    PLoS Negl Trop Dis; 2012; 6(3):e1567. PubMed ID: 22448291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The V protein of mumps virus plays a critical role in pathogenesis.
    Xu P; Luthra P; Li Z; Fuentes S; D'Andrea JA; Wu J; Rubin S; Rota PA; He B
    J Virol; 2012 Feb; 86(3):1768-76. PubMed ID: 22090137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.
    Rubin SA; Afzal MA; Powell CL; Bentley ML; Auda GR; Taffs RE; Carbone KM
    J Infect Dis; 2005 Apr; 191(7):1123-8. PubMed ID: 15747248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
    Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
    J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of live mumps virus vaccines.
    Furesz J
    J Med Virol; 2002 Jul; 67(3):299-300. PubMed ID: 12116018
    [No Abstract]   [Full Text] [Related]  

  • 16. Mumps vaccine virus strains and aseptic meningitis.
    Bonnet MC; Dutta A; Weinberger C; Plotkin SA
    Vaccine; 2006 Nov; 24(49-50):7037-45. PubMed ID: 16884835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of non-human primates in the neurological safety of live viral vaccines (review).
    Levenbook I
    Biologicals; 2011 Jan; 39(1):1-8. PubMed ID: 21183358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovirulence safety testing of mumps vaccines--historical perspective and current status.
    Rubin SA; Afzal MA
    Vaccine; 2011 Apr; 29(16):2850-5. PubMed ID: 21334386
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.